« Back to the previous page

Also available in:

Buyer for CRO phase I clinical trial company in Europe

Company to buy

  • Size: small to mid-sized business
  • Revenue: 3-10 M EUR
  • Location of the target company: Europe. 
  • Reason for acquisition: The company wants a Contract Research Organization phase 1 clinical trial. 
  • #CFIE PHB077

Overview of CRO Phase I clinical trial company wanted

This buyer is looking for a new acquisition in Europe. The company is interested to CRO phase 1 clinical in Europe to expand the operation.

Profile (strategy) of CRO Phase I clinical trial company

A leading global Clinical Research Organization (CRO) with more than 1500 employees across the globe. The company has made several acquisitions through the years, expanding their products around the world. Offers and end to end service, covering the entire spectrum of clinical research from phase I to IV. The company’s revenue is more than USD 50 million and has a 20% YoY CAGR. The company has the approval of FDA, ANVISA, WHO, CDSCO, MHRA and others. The services include pharmacovigilance, phase I – IV, bioavailability and bioequivalence, bioanalytical, data services, medical writing etc. 

Contact this buyer of a CRO phase I clinical trial

Contact us to get details about this buyer of CRO phase I clinical trial companies now

Activities and products of the target for CRO phase 1 clinical trial company

The buyer company is already operating in multiple region, with presence in Asia, Europe and North America. Now the buyer company wants to strengthen its presence in Europe and expand the operation.

The buyer is following an expansion strategy. Feel free to contact us in case you want to know more about this buyer.

The goal of the buyer is to acquire a profitable company with Revenue in the range of 3 – 10 million euro.


Highlights of the CRO phase 1 clinical trial company buyer

  • The buyer is a contract research organization company based in India.
  • Revenue USD 50+ million and a 20% CAGR.
  • More than 15 regulatory audits for pharmacovigilance.
  • Acquisition background.

Information about this Buyer for CRO phase 1 clinical trial company

Feel free to contact us for more information regarding this CRO phase 1 clinical trial company wanted in Europe or if you know possible interested or suited parties. For more CRO phase 1 clinical trial company, please visit the section pharmaceutical companies wanted. For pharmaceutical manufacturing firm for sale visit the section pharmaceutical companies for sale.


Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company we assess the likelihood of a future transaction. We only get back to you if we see a realistic opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual please explain as much as possible about your personal background strategy and fit with the target. There is also a possibility that your details will be kept on file and we will get back to you once there is an opportunity to do a transaction. CFIE can’t guarantee you will receive an answer to your request.